Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment

European Respiratory Journal

Volumn 16, Issue 1, 2000, Pages 95-100

  Jobsis Q ^a,b   Raatgeep, H C ^a   Schellekens, S L ^a   Kroesbergen, A ^a   Hop, W C J ^a   De Jongste, J C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotics; Children; Cystic fibrosis; Exhaled air; Hydrogen Peroxide; Nitric oxide

Indexed keywords

ANTIBIOTIC AGENT; HYDROGEN PEROXIDE; NITRIC OXIDE;

ADOLESCENT; ADULT; AIRWAY DYNAMICS; ANTIBIOTIC THERAPY; ARTICLE; BREATHING MECHANICS; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BREATH TESTS; CHILD; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYDROGEN PEROXIDE; MALE; NITRIC OXIDE; RESPIRATORY TRACT INFECTIONS;

EID: 0343962241     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16a17.x     Document Type: Article

References (36)

1. Armstrong DS, Grimwood K, Carlin JB, et al. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156: 1197-1204.
2. Davis PB, Drumm M, Konstan MW. State of the art: cystic fibrosis. Am J Respir Crit Care Med 1996; 154: 1229-1256.
3. Bonfield TL, Panuska JR, Konstan MW, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
4. Dean TP, Dai Y, Shute JK, Church MK, Warner JO. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis. Pediatr Res 1993; 34: 159-161.
5. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448-454.
6. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-1082.
7. Winklhofer-Roob BM. Oxygen free radicals and antioxidants in cystic fibrosis: the concept of an oxidant-antioxidant imbalance. Acta Paediatr Suppl 1994; 83: 49-57.
8. McGrath LT, Mallon P, Dowey L, et al. Oxidative stress during acute respiratory exacerbations in cystic fibrosis. Thorax 1999; 54: 518-523.
9. Kharazmi A, Rechnitzer C, Schiotz PO, Jensen T, Back L, Hoiby N. Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest 1987; 17: 256-261.
10. Hull J, Vervaart P, Grimwood K, Phelan P. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax 1997; 52: 557-560.
11. Scheideler L, Manke HG, Schwulera U, Inacker O, Hämmerle H. Detection of nonvolatile macromolecules in breath: a possible diagnostic tool? Am Rev Respir Dis 1993; 148: 778-784.
12. Jöbsis Q, Raatgeep HC, Hermans PWM, de Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997; 10: 519-521.
13. Loukides S, Horvath I, Wodehouse T, Cole PJ, Barnes PJ. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 1998; 158: 991-994.
14. Dekhuijzen PNR, Aben KKH, Dekker I, et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 813-816.
15. Kietzmann D, Kahl R, Müller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993; 19: 78-81.
16. Lundberg JON, Weitzberg E, Lundberg JM, Alving K. Nitric oxide in exhaled air. Eur Respir J 1996; 9: 2671-2680.
17. Kharitonov SA, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J 1997; 10: 1683-1693.
18. Lundberg JON, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Childhood 1996; 75: 323-326.
19. Dötsh J, Demirakça S, Terbrack HG, Hüls G, Rascher W, Kühl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J 1996; 9: 2537-2540.
20. Hyslop PA, Sklar LA. A quantitative fluorimetric assay for the determination of oxidant production by polymorphonuclear leukocytes: its use in the simultaneous fluorimetric assay of cellular activation processes. Anal Biochem 1984; 141: 280-286.
21. Jöbsis Q, Raatgeep HC, Schellekens SL, Hop WCJ, Hermans PWM, de Jongste JC. Hydrogen peroxide in exhaled air of healthy children: reference values. Eur Respir J 1998; 12: 483-485.
22. Ho LP, Faccenda J, Innes JA, Greening AP. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999; 13: 103-106.
23. Dauletbaev N, Diegel H, Berkefeld M, et al. Monitoring the salivary contamination of breath condensate by measuring alpha-amylase and urea. Eur Respir J 1999; 14: 166s.
24. Jöbsis O, Schellekens SL, Kroesbergen A, Hop WCJ, de Jongste JC. Sampling of exhaled nitric oxide in children: end-expiratory plateau, balloon and tidal breathing methods compared. Eur Respir J 1999; 13: 1406-1410.
25. Kroesbergen A, Jöbsis Q, Bel EHD, Hop WCJ, de Jongste JC. Flow-dependency of exhaled nitric oxide in children with asthma and cystic fibrosis. Eur Respir J 1999; 14: 871-875.
26. Zapletal A, Samanek M, Paul T. Lung Function in Children and Adolescents: Methods, Reference Values. Basle, Karger Verlag, 1987; pp. 191-197.
27. BMDP Statistical Software Manual. Unbalanced repeated measures models with structured covariance matrices. Berkeley, CA, USA, University of California Press, 1992: pp. 1330-1335.
28. Wood AJJ. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996; 335: 179-188.
29. Worlitzsch D, Herbeth G, Ulrich M, Döring G. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 1998; 11: 337-383.
30. Henson PM, Johnston RB. Tissue injury in inflammation. J Clin Invest 1987; 79: 669-674.
31. Greening AP, Lowrie DB. Extracellular release of hydrogen peroxide by human alveolar macrophages: the relationship to cigarette smoking and lower respiratory tract infections. Clin Sci 1983; 65: 661-664.
32. Range SP, Dunster C, Knox AJ, Kelly FJ. Treatment of pulmonary exacerbations of cystic fibrosis leads to improved antioxidant status. Eur Respir J 1999; 13: 560-564.
33. Canady RG, Platt-Mills T, Murphy A, Johannesen R, Gaston B. Vital capacity reservoir and online measurement of childhood nitrosopnea are linearly related: clinical implications. Am J Respir Crit Care Med 1999; 159: 311-314.
34. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998; 12: 1290-1294.
35. Jöbsis Q, Kroesbergen A, Schellekens SL, de Jongste JC. Nitric oxide in exhaled air of healthy children, sampled with the balloon method. Am J Respir Crit Care Med 1998; 157: A469.
36. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998; 53: 680-684.